EBS Emergent BioSolutions Inc. Common Stock
$4,62
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$4–$14
3% of range
Calificación del Analista
BUY
6 analysts
Precio Objetivo
$11
+138% upside
P/E (TTM)
5.0
ROE
9.9%
Margen de Beneficio Neto
7.1%
EBS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.62
Capitalización Bursátil
$241M
P/E (TTM)
5.0
BPA (TTM)
$0.93
Ingresos (TTM)
$743M
Rendimiento div.
—
ROE
9.9%
Deuda/Capital
1.1
Rango 52S
$4 – $14
EBS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$743M
2017-12-31
→
2025-12-31
BPA
$0.93
2017-12-31
→
2025-12-31
Flujo de caja libre
$157M
2017-12-31
→
2025-12-31
Márgenes
7.1%
2022-12-31
→
2023-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
EBS
Mediana de Pares
P/E (TTM)
5.0
88.5
P/S (TTM) (P/V (TTM))
0.3
1.7
P/B (P/C)
0.5
3.6
EV / EBITDA
3.1
—
Price / FCF (Precio / FCF)
1.5
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
EBS
Mediana de Pares
Operating Margin (Margen Operativo)
13.5%
—
Net Profit Margin (Margen de Beneficio Neto)
7.1%
-35.8%
ROA
3.9%
-38.8%
ROE
9.9%
-61.0%
ROIC
5.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
EBS
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
1.1
0.0
Current Ratio (Ratio corriente)
5.0
3.9
Quick Ratio (Ratio Rápido)
2.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
EBS
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-28.8%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
-12.7%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
-14.0%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
EBS
Mediana de Pares
EBS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
6 analistas
- Compra fuerte 1 16,7%
- Compra 4 66,7%
- Mantener 1 16,7%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
2 analistas · 2026-08-17
Mediana
$11.00
← Por Debajo de Todos los Objetivos
$4.62
Mín
$10.00
Máx
$12.00
Objetivo mediano
$11.00
+138,1%
Objetivo medio
$11.00
+138,1%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.42%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $0.60 | $0.11 | 0.49% |
| 31 de marzo de 2026 | $0.21 | $-0.25 | 0.46% |
| 31 de diciembre de 2025 | $-0.43 | $0.11 | -0.54% |
| 30 de septiembre de 2025 | $1.06 | $-0.12 | 1.2% |
| 30 de junio de 2025 | $0.16 | $-0.49 | 0.65% |
| 31 de marzo de 2025 | $0.71 | $0.44 | 0.27% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Balance general 30
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Flujo de Efectivo 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Tasas de Crecimiento 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | -108,300,000 | 53,200,000 | 54,200,000 | 54,400,000 | -104,900,000 | 53,100,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | -111,300,000 | 56,500,000 | 54,200,000 | 57,300,000 | -107,400,000 | 55,600,000 | 52,600,000 | 52,200,000 | -101,500,000 | 51,800,000 | 50,700,000 | 50,200,000 | -100,500,000 | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Balance general 30
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Flujo de Efectivo 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $762M | $750M | · | $888M | $912M | $1.07B | · | $1.12B | $1.16B | $1.07B | · | $1.10B | $1.07B | $977M | · | $1.52B | |
| Net Income TTM | $-134M | $114M | · | $222M | $-112M | $-91M | · | $-423M | $-799M | $-702M | · | $-778M | $-602M | $-393M | · | $48M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -3.1 | 4.3 | · | 2.2 | -2.7 | -2.5 | · | -1.0 | -0.4 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 30.0 | |
| P/S | 0.6 | 0.6 | · | 0.5 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| P / FCF | · | -11.9 | · | · | · | -17.9 | · | · | · | -1.8 | · | · | · | -2.6 | · | · | |
| EV / EBITDA | -7.0 | 24.8 | · | 11.5 | 464.4 | 10.4 | · | 15.0 | -7.7 | 21.0 | · | -5.6 | -5.6 | -21.5 | · | -44.8 | |
| EV / FCF | · | -23.3 | · | · | · | -52.8 | · | · | · | -19.3 | · | · | · | -12.3 | · | · | |
| EV / Revenue | 1.1 | 1.1 | · | 1.0 | 0.8 | 0.7 | · | 0.9 | 1.3 | 1.3 | · | 1.2 | 1.5 | 2.5 | · | 1.2 | |
| Earnings Yield | -32.6% | 23.5% | · | 44.7% | -36.8% | -40.3% | · | -98.6% | -226.5% | -544.7% | · | -449.7% | -162.7% | -75.9% | · | 3.3% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Ingresos | $743M | $1.04B | $1.05B | $1.12B | — |
| Margen Bruto % | — | — | 30.3% | 34.3% | — |
| Margen Operativo % | 13.5% | -10.4% | -69.2% | -15.2% | — |
| Beneficio neto | $53M | $-191M | $-760M | $-212M | — |
| EPS Diluido | $0.93 | $-3.60 | $-14.85 | $-4.22 | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 1.1 | 1.4 | 2.0 | — | — |
| Ratio corriente | 5.0 | 3.7 | 1.0 | — | — |
| Ratio Rápido | 2.2 | 1.6 | 0.5 | — | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $157M | $36M | $-258M | $-150M | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 212 declarantes · $262.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 36 (+2 vs trimestre anterior) | 24 (+2 vs trimestre anterior) | 65 (+2 vs trimestre anterior) | 61 (+6 vs trimestre anterior) | +3.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | $24 599 540 | 2 935 506 | 9,36% | Acciones |
| STATE STREET CORP | $24 556 367 | 2 929 238 | 9,34% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $23 216 354 | 2 770 448 | 8,83% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $18 426 271 | 2 198 839 | 7,01% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10 062 629 | 1 200 791 | 3,83% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $9 567 235 | 1 141 339 | 3,64% | Acciones |
| OAK HILL ADVISORS LP | $9 329 772 | 1 113 338 | 3,55% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $8 984 910 | 1 072 185 | 3,42% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 626 129 | 1 029 371 | 3,28% | Acciones |
| Prescott Group Capital Management, L.L.C. | $6 475 821 | 772 771 | 2,46% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $5 725 610 | 683 247 | 2,18% | Acciones |
| PRUDENTIAL FINANCIAL INC | $5 719 308 | 682 495 | 2,18% | Acciones |
| D. E. Shaw & Co., Inc. | $5 572 440 | 664 969 | 2,12% | Acciones |
| GOLDMAN SACHS GROUP INC | $4 591 829 | 547 951 | 1,75% | Acciones |
| Allianz Asset Management GmbH | $4 556 885 | 543 781 | 1,73% | Acciones |
| PALISADE CAPITAL MANAGEMENT, LP | $4 316 191 | 515 059 | 1,64% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $4 306 516 | 513 904 | 1,64% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $4 091 820 | 488 284 | 1,56% | Acciones |
| VANGUARD GROUP INC | $4 091 457 | 331 024 | 1,56% | Acciones |
| Prosight Management, LP | $3 854 398 | 459 952 | 1,47% | Acciones |
| Trexquant Investment LP | $3 753 050 | 447 858 | 1,43% | Acciones |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3 690 745 | 440 423 | 1,40% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $2 966 378 | 353 983 | 1,13% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 863 614 | 341 720 | 1,09% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $2 757 523 | 329 060 | 1,05% | Acciones |
| Values First Advisors, Inc. | $2 526 468 | 301 488 | 0,96% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 420 144 | 288 800 | 0,92% | Opción de compra |
| GLOBEFLEX CAPITAL L P | $2 022 077 | 241 298 | 0,77% | Acciones |
| FMR LLC | $1 790 865 | 213 707 | 0,68% | Acciones |
| Brandywine Global Investment Management, LLC | $1 610 632 | 130 310 | 0,61% | Acciones |
| DEUTSCHE BANK AG\ | $1 591 513 | 189 918 | 0,61% | Acciones |
| Morse Asset Management, Inc | $1 536 339 | 183 334 | 0,58% | Acciones |
| WOLVERINE ASSET MANAGEMENT LLC | $1 465 939 | 174 933 | 0,56% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $1 390 066 | 165 879 | 0,53% | Acciones |
| ARISTEIA CAPITAL, L.L.C. | $1 355 490 | 161 753 | 0,52% | Acciones |
| Squarepoint Ops LLC | $1 240 374 | 148 016 | 0,47% | Acciones |
| CREDIT AGRICOLE S A | $1 225 994 | 146 300 | 0,47% | Acciones |
| FRANKLIN RESOURCES INC | $1 140 518 | 136 100 | 0,43% | Acciones |
| Bank of New York Mellon Corp | $1 107 082 | 132 110 | 0,42% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 038 232 | 123 894 | 0,39% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 028 000 | 122 700 | 0,39% | Acciones |
| FULLER & THALER ASSET MANAGEMENT, INC. | $946 647 | 112 965 | 0,36% | Acciones |
| SILVER OAK SECURITIES, INCORPORATED | $929 024 | 110 862 | 0,35% | Acciones |
| CITADEL ADVISORS LLC | $850 570 | 101 500 | 0,32% | Opción de compra |
| Soviero Asset Management, LP | $838 000 | 100 000 | 0,32% | Acciones |
| MACKENZIE FINANCIAL CORP | $817 151 | 97 512 | 0,31% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $810 346 | 96 700 | 0,31% | Acciones |
| Cetera Investment Advisers | $807 002 | 96 301 | 0,31% | Acciones |
| UBS Group AG | $801 765 | 95 676 | 0,31% | Acciones |
| SEGALL BRYANT & HAMILL, LLC | $797 818 | 95 205 | 0,30% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785 206 | 93 700 | 0,30% | Opción de venta |
| Sanctuary Advisors, LLC | $746 800 | 89 117 | 0,28% | Acciones |
| MORGAN STANLEY | $734 281 | 87 623 | 0,28% | Acciones |
| MARTINGALE ASSET MANAGEMENT L P | $656 205 | 78 306 | 0,25% | Acciones |
| EVOLVE PRIVATE WEALTH, LLC | $592 801 | 70 740 | 0,23% | Acciones |
| TWO SIGMA ADVISERS, LP | $561 144 | 45 400 | 0,21% | Acciones |
| RHUMBLINE ADVISERS | $560 997 | 66 946 | 0,21% | Acciones |
| Man Group plc | $557 496 | 66 527 | 0,21% | Acciones |
| JANE STREET GROUP, LLC | $552 242 | 65 900 | 0,21% | Opción de compra |
| LPL Financial LLC | $543 828 | 64 896 | 0,21% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $539 334 | 64 980 | 0,21% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $529 624 | 63 201 | 0,20% | Acciones |
| CITIGROUP INC | $527 219 | 62 914 | 0,20% | Acciones |
| JAMES INVESTMENT RESEARCH, INC. | $519 250 | 61 963 | 0,20% | Acciones |
| CITADEL ADVISORS LLC | $506 990 | 60 500 | 0,19% | Opción de venta |
| Palumbo Wealth Management LLC | $490 557 | 58 539 | 0,19% | Acciones |
| IEQ CAPITAL, LLC | $488 152 | 58 252 | 0,19% | Acciones |
| Assenagon Asset Management S.A. | $473 093 | 56 455 | 0,18% | Acciones |
| Mariner, LLC | $467 769 | 55 817 | 0,18% | Acciones |
| FEDERATED HERMES, INC. | $461 621 | 55 086 | 0,18% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $416 939 | 49 754 | 0,16% | Acciones |
| Vanguard Global Advisers, LLC | $407 888 | 48 674 | 0,16% | Acciones |
| Advantage Alpha Capital Partners LP | $405 156 | 45 936 | 0,15% | Acciones |
| Rafferty Asset Management, LLC | $397 463 | 47 430 | 0,15% | Acciones |
| WINTON GROUP Ltd | $383 335 | 45 744 | 0,15% | Acciones |
| Quantinno Capital Management LP | $375 784 | 44 843 | 0,14% | Acciones |
| ExodusPoint Capital Management, LP | $367 731 | 43 882 | 0,14% | Acciones |
| TRUIST FINANCIAL CORP | $365 966 | 43 671 | 0,14% | Acciones |
| WOLVERINE TRADING, LLC | $353 130 | 39 500 | 0,13% | Opción de venta |
| Brevan Howard Capital Management LP | $326 116 | 38 916 | 0,12% | Acciones |
| Integrated Quantitative Investments LLC | $322 638 | 38 501 | 0,12% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $292 462 | 34 900 | 0,11% | Acciones |
| Cambria Investment Management, L.P. | $285 247 | 34 039 | 0,11% | Acciones |
| CWM, LLC | $280 017 | 33 737 | 0,11% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $278 392 | 33 221 | 0,11% | Acciones |
| WOLVERINE TRADING, LLC | $272 670 | 30 500 | 0,10% | Opción de compra |
| OPPENHEIMER ASSET MANAGEMENT INC. | $265 202 | 31 647 | 0,10% | Acciones |
| MetLife Investment Management, LLC | $250 839 | 29 933 | 0,10% | Acciones |
| Keystone Financial Group | $238 730 | 28 488 | 0,09% | Acciones |
| BANK OF MONTREAL /CAN/ | $229 847 | 27 428 | 0,09% | Acciones |
| BlackRock, Inc. | $225 045 | 26 855 | 0,09% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $221 391 | 26 419 | 0,08% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $216 237 | 25 804 | 0,08% | Acciones |
| WOLVERINE TRADING, LLC | $208 928 | 23 370 | 0,08% | Acciones |
| State of Wyoming | $203 408 | 24 273 | 0,08% | Acciones |
| PROFUND ADVISORS LLC | $202 360 | 24 148 | 0,08% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $198 054 | 24 603 | 0,08% | Acciones |
| Glenmede Investment Management, LP | $183 438 | 20 798 | 0,07% | Acciones |
| Graham Capital Management, L.P. | $180 941 | 21 592 | 0,07% | Acciones |
| DIVERSIFIED TRUST CO | $173 625 | 20 719 | 0,07% | Acciones |
Informantes de la empresa 47 insiders · 10 directivos · 5 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | Chief Executive Officer | 5 de junio de 2018 S | 197 343 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 8 de junio de 2026 F | 374 083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 13 de marzo de 2012 A | 26 614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 1 de julio de 2026 S | 159 098 | 0 | 1 | $-25 200 |
| William Hartzel | SVP, Bioservices | 8 de junio de 2026 F | 185 558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 8 de junio de 2026 F | 202 201 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 13 de noviembre de 2015 S | 25 182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 14 de marzo de 2013 F | 28 000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 15 de marzo de 2011 A | 18 759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 11 de noviembre de 2010 M | 6 980 | 0 | 0 | $0 |
| John D Fowler JR | Consejero | 30 de abril de 2026 A | 30 350 | 0 | 0 | $0 |
| Fuad El-Hibri | Consejero | 3 de diciembre de 2021 J | 206 434 | 0 | 0 | $0 |
| John Niederhuber | Consejero | 18 de mayo de 2016 D | 30 300 | 0 | 0 | $0 |
| Shahzad Malik | Consejero | 14 de junio de 2007 A | — | 0 | 0 | $0 |
| Intervac, L.L.C. | Propietario del 10% | 18 de septiembre de 2012 J | 4 344 250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | Propietario del 10% | 27 de mayo de 2010 J | 2 265 043 | 0 | 0 | $0 |
| Microscience Investments LTD | Propietario del 10% | 8 de marzo de 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | — | 30 de abril de 2026 A | 149 076 | 0 | 0 | $0 |
| Ronald Richard | — | 30 de abril de 2026 A | 123 761 | 0 | 2 | $-263 101 |
| Keith Katkin | — | 30 de abril de 2026 A | 96 294 | 0 | 1 | $-128 183 |
| Joseph C Papa | — | 29 de abril de 2026 A | 493 153 | 0 | 0 | $0 |
| Kathryn C Zoon | — | 30 de abril de 2025 A | 78 885 | 0 | 0 | $0 |
| Donald W Degolyer | — | 30 de abril de 2025 A | 145 503 | 0 | 0 | $0 |
| Sujata Tyagi Dayal | — | 30 de abril de 2025 A | 97 532 | 0 | 0 | $0 |
| Neal Franklin Fowler | — | 30 de abril de 2025 A | 135 503 | 0 | 0 | $0 |
| Marvin L White | — | 30 de abril de 2025 A | 88 495 | 0 | 0 | $0 |
| Louis W Sullivan | — | 30 de abril de 2025 A | 139 098 | 0 | 0 | $0 |
| Simon C Lowry | — | 6 de marzo de 2025 A | 91 982 | 0 | 0 | $0 |
| Jessica Perl | — | 6 de marzo de 2025 A | 68 387 | 0 | 0 | $0 |
| Jennifer Lynne Fox | — | 11 de julio de 2024 A | 186 382 | 0 | 0 | $0 |
| Adam Havey | — | 9 de junio de 2023 A | 174 398 | 0 | 0 | $0 |
| Robert Kramer | — | 9 de junio de 2023 A | 506 059 | 0 | 0 | $0 |
| Jerome M Hauer | — | 25 de mayo de 2023 A | 57 508 | 0 | 0 | $0 |
| Katherine Strei | — | 28 de febrero de 2023 F | 62 824 | 0 | 0 | $0 |
| Atul Saran | — | 28 de febrero de 2023 F | 86 645 | 0 | 0 | $0 |
| George A Joulwan | — | 26 de mayo de 2022 A | 40 244 | 0 | 0 | $0 |
| Karen L. Smith | — | 7 de mayo de 2021 F | 11 888 | 0 | 0 | $0 |
| Sean Kirk | — | 31 de marzo de 2021 F | 17 776 | 0 | 0 | $0 |
| Sue Bailey | — | 4 de marzo de 2021 S | 24 427 | 0 | 0 | $0 |
| Denise Esposito | — | 10 de marzo de 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | — | 4 de junio de 2008 S | 1 399 764 | 0 | 0 | $0 |
| Joe M Allbaugh | — | 21 de mayo de 2008 A | — | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | — | 28 de marzo de 2008 S | 1 269 390 | 0 | 0 | $0 |
| Mauro Gibellini | — | 4 de junio de 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | — | 17 de mayo de 2007 P | 1 000 | 0 | 0 | $0 |
| Edward Arcuri | — | 8 de mayo de 2007 M | 76 722 | 0 | 0 | $0 |
| Robert Calvin Myers | — | 20 de noviembre de 2006 C | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 23 de agosto de 2010 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 78 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| EWO · iShares, Inc. | 24,34% | 347 883 SH | 8 de agosto de 2026 | Diario |
| EUFN · iShares Trust | 1,16% | 352 361 SH | 8 de agosto de 2026 | Diario |
| MTRA · Invesco Actively Managed Exchange-T… | 1,12% | 11 534 SH | 8 de agosto de 2026 | Diario |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0,69% | 35 928 SH | 8 de agosto de 2026 | Diario |
| IDMO · Invesco Exchange-Traded Fund Trust … | 0,66% | 201 926 SH | 8 de agosto de 2026 | Diario |
| EZU · iShares, Inc. | 0,54% | 381 737 SH | 8 de agosto de 2026 | Diario |
| DMXF · iShares Trust | 0,39% | 26 552 SH | 8 de agosto de 2026 | Diario |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,35% | 2 821 000 | 8 de agosto de 2026 | Diario |
| IEV · iShares Trust | 0,31% | 37 421 SH | 8 de agosto de 2026 | Diario |
| IVLU · iShares Trust | 0,31% | 99 461 SH | 8 de agosto de 2026 | Diario |
| IMTM · iShares Trust | 0,30% | 91 595 SH | 8 de agosto de 2026 | Diario |
| IXG · iShares Trust | 0,28% | 13 907 SH | 8 de agosto de 2026 | Diario |
| IEUR · iShares Trust | 0,26% | 171 214 SH | 8 de agosto de 2026 | Diario |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,24% | 673 051 SH | 8 de agosto de 2026 | Diario |
| PABD · iShares Trust | 0,22% | 5 313 SH | 8 de agosto de 2026 | Diario |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,20% | 312 634 SH | 8 de agosto de 2026 | Diario |
| EFG · iShares Trust | 0,20% | 236 854 SH | 8 de agosto de 2026 | Diario |
| EFV · iShares Trust | 0,19% | 412 501 SH | 8 de agosto de 2026 | Diario |
| EFA · iShares Trust | 0,19% | 1 084 946 SH | 8 de agosto de 2026 | Diario |
| FSCC · Federated Hermes ETF Trust | 0,17% | 51 825 NS | 31 de mayo de 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,17% | 18 243 NS | 31 de mayo de 2026 | N-PORT |
| IEFA · iShares Trust | 0,17% | 2 281 517 SH | 8 de agosto de 2026 | Diario |
| ESGD · iShares Trust | 0,16% | 138 616 SH | 8 de agosto de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,15% | 91 705 NS | 30 de abril de 2026 | N-PORT |
| IDEV · iShares Trust | 0,15% | 333 751 SH | 8 de agosto de 2026 | Diario |
| ACWX · iShares Trust | 0,12% | 96 686 SH | 8 de agosto de 2026 | Diario |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,11% | 2 737 509 SH | 8 de agosto de 2026 | Diario |
| VSGX · VANGUARD WORLD FUND | 0,11% | 56 354 SH | 8 de agosto de 2026 | Diario |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,11% | 22 740 SH | 8 de agosto de 2026 | Diario |
| IXUS · iShares Trust | 0,10% | 423 874 SH | 8 de agosto de 2026 | Diario |
| CALF · Pacer Funds Trust | 0,10% | 412 173 NS | 30 de abril de 2026 | N-PORT |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 655 464 SH | 8 de agosto de 2026 | Diario |
| VXUS · VANGUARD STAR FUNDS | 0,08% | 4 120 164 SH | 8 de agosto de 2026 | Diario |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 757 640 NS | 31 de mayo de 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2 270 234 NS | 31 de mayo de 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 177 050 SH | 8 de agosto de 2026 | Diario |
| GSSC · Goldman Sachs ETF Trust | 0,06% | 67 946 NS | 31 de mayo de 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 895 SH | 8 de agosto de 2026 | Diario |
| URTH · iShares, Inc. | 0,05% | 28 246 SH | 8 de agosto de 2026 | Diario |
| ACWI · iShares Trust | 0,04% | 100 105 SH | 8 de agosto de 2026 | Diario |
| SMLF · iShares Trust | 0,03% | 269 476 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 98 804 NS | 31 de mayo de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,03% | 283 798 NS | 30 de abril de 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 242 129 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 45 382 SH | 8 de agosto de 2026 | Diario |
| TMFX · RBB Fund, Inc. | 0,02% | 845 NS | 31 de mayo de 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,02% | 372 675 NS | 30 de abril de 2026 | N-PORT |
| CRBN · iShares Trust | 0,02% | 1 830 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 118 597 SH | 8 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,02% | 355 059 SH | 8 de agosto de 2026 | Diario |